rpoB, katG and inhA mutations in multi-drug resistant strains of Mycobacterium tuberculosis clinical isolates from southeast Mexico. 2019

Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
Instituto de Salud Pública, Universidad Veracruzana, Veracruz, Mexico. Electronic address: robzencue@gmail.com.

BACKGROUND Previous knowledge of molecular mechanisms related with multi-drug resistances in tuberculosis is important if molecular diagnostic procedures want to be used in specific geographical regions. For that reason, the aim of this study was to investigate the mutations at rpoB, katG and inhA in multi-drug resistant tuberculosis isolates from Southeast Mexico. METHODS Isolates of tuberculosis with a confirmed resistance against rifampicin and isoniazid were collected and sequencing analysis was performed of the rpoB rifampicin resistance-determining region, the katG and the encoding region of inhA. RESULTS Of 74 isolates with multidrug resistance, 34 (46%) presented six mutations in katG; the most abundant was katG315 in 29 (39%) isolates. At inhA, nine (11%) isolates presented three mutations; the most frequent was inhA21, located in five (6%) strains. Eleven polymorphisms were observed at rpoB in 61 (82%) isolates, prevailing rpoB531 and rpoB 526 in 48 (64%) and ten (12%) isolates, respectively. Eleven double combinations were observed in 39 (52%) isolates, the most common of which was rpoB531+katG315, found in 22 (29%) strains. CONCLUSIONS This study provides valuable information on the diversity of polymorphisms in genes related to multidrug-resistant tuberculosis, as well as the presence of new mutations not previously described; this information should be considered in the implementation of molecular diagnostic tests.

UI MeSH Term Description Entries
D008297 Male Males
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010088 Oxidoreductases The class of all enzymes catalyzing oxidoreduction reactions. The substrate that is oxidized is regarded as a hydrogen donor. The systematic name is based on donor:acceptor oxidoreductase. The recommended name will be dehydrogenase, wherever this is possible; as an alternative, reductase can be used. Oxidase is only used in cases where O2 is the acceptor. (Enzyme Nomenclature, 1992, p9) Dehydrogenases,Oxidases,Oxidoreductase,Reductases,Dehydrogenase,Oxidase,Reductase
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
September 2020, Journal of global antimicrobial resistance,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
November 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
January 2023, Indian journal of medical microbiology,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
December 2003, Antimicrobial agents and chemotherapy,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
March 2007, The Southeast Asian journal of tropical medicine and public health,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
January 2005, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
September 2003, Journal of clinical microbiology,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
June 2015, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
March 2018, BMC microbiology,
Roberto Zenteno-Cuevas, and Betzaida Cuevas-Córdoba, and Aurora Parissi-Crivelli
January 2007, Tuberkuloz ve toraks,
Copied contents to your clipboard!